A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional Labeling
Trial
N/A
Completed
Nov. 19, 2024
Impact of Intensive Outpatient Rehabilitation on Non-Motor Patient-Reported Outcomes in Parkinson's Disease (INTENSO)
Trial
N/A
Completed
Nov. 18, 2024
A Smartphone Based, Titrated Exercise Solution for Patients With Parkinson's Disease in Daily Life: Pilot Study
Trial
N/A
Completed
Nov. 17, 2024
Forensic Handwriting Analysis in People with Parkinson's Disease - Pilot Study
Trial
N/A
Completed
Nov. 17, 2024
The Relation Between the Prognosis of Subthalamic Nucleus Deep Brain Stimulation Surgery by Microlesion Effect and Electrode Position
Trial
N/A
Enrolling by invitation
Nov. 11, 2024
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease
Trial
Phase 1
Completed
Nov. 11, 2024
Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson Disease
Trial
N/A
Completed
Nov. 7, 2024
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
Trial
N/A
Recruiting
Nov. 7, 2024
Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study
Trial
N/A
Completed
Nov. 7, 2024
High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease.
Trial
N/A
Completed
Nov. 7, 2024
7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
Trial
N/A
Recruiting
Nov. 7, 2024
The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease
Trial
Phase 1
Recruiting
Nov. 6, 2024
Objective Assessment of Behavioural Disorders in PD
Trial
N/A
Active, not recruiting
Nov. 5, 2024
Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as LGBTQ+
Trial
N/A
Suspended
Nov. 5, 2024
North American Prodromal Synucleinopathy Consortium
Trial
N/A
Enrolling by invitation
Nov. 5, 2024
Exercise & Brain Energetics in PD
Trial
N/A
Recruiting
Nov. 5, 2024
Effects of Unblocking the Full Potential of Percept PC IPG
Trial
N/A
Completed
Nov. 3, 2024
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Trial
Phase 1
Completed
Oct. 31, 2024
The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease
Trial
Phase 1
Recruiting
Oct. 31, 2024